glp-1 in psych patients receptor agonists are proving to be a valuable resource our psychiatric toolkit, particularly for struggling with binge eating disorder. The appetite-regulating and… | Maria Isabel Arguello Guerra Frontiers | Psychiatric adverse events

111 Additionally, orlistat was shown to be superior to COCPs in terms of anthropometric outcomes, but not in metabolic outcomes 109 (Table 1)

T.HuentelmanM

Wegovy, in particular, is FDA-approved for weight loss in adults with obesity or overweight, and has shown consistent, proven results in clinical studies, with patients achieving significant weight reduction when combined with a reduced-calorie diet and increased physical activity

Valerie Mendenhall, who has been on GLP-1 medications for several years, said the drugs have changed her life

Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions

Structured strength (resistance) training or mixed training (resistance plus aerobic) [160] programs are well established to help preserve lean mass during weight reduction [58]